1-2 of 2
Mariefel Vendivil, RN
Close
Sort by
Journal Articles

Prospective Analysis of Bortezomib, Fludarabine and Melphalan As Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation for Multiple Myeloma

Phyllis McKiernan, David S Siegel, MD PhD, David H. Vesole, MD PhD, Tracy Andrews, MSc, Noa Biran, MD, Scott D. Rowley, MD, Alan P Skarbnik, MD, Andrew L. Pecora, MD, Jacquelyn Callahan, RN, Andrea Ortega, RN, Mariefel Vendivil, RN, Supreet Kaur, MD, Marshall McKenna, MD, Michele L. Donato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1020.
https://doi.org/10.1182/blood-2018-99-117313
Published: 2018
Journal Articles

Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies - Cpit-001 Trial

Alan P Skarbnik, MD, Michele L. Donato, MD, Scott D. Rowley, MD, Andre Goy, MD, David H. Vesole, MD, Pashna N. Munshi, MD, David Siegel, MD PhD, Noa Biran, MD, Joshua R Richter, MD, Tatyana A Feldman, MD, Lori A. Leslie, MD, Mary E Dilorenzo, APN, Phyllis McKiernan, APN, MSN, Melissa Baker, MSN, ANP, Michele Boonstra, APN, Michele Simone, APN, Ann McNeill, ANP, Ernest Richards, PhD, Joshua Zenreich, Mariefel Vendivil, RN, Andrea Ortega, RN, Jacquelyn Callahan, RN, Michael B Atkins, MD, Andrew L. Pecora, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 340.
https://doi.org/10.1182/blood.V130.Suppl_1.340.340
Published: 2017